Literature DB >> 9062474

Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma.

D Russo1, S Tumino, F Arturi, P Vigneri, G Grasso, A Pontecorvi, S Filetti, A Belfiore.   

Abstract

Thyroid carcinomas, even when well differentiated, usually appear as hypofunctioning at scintigraphy. We report a case of an aggressive insular thyroid carcinoma presenting as an autonomously functioning thyroid nodule and causing severe thyrotoxicosis. The tumor was metastatic to a cervical lymph node and both lungs. An activating mutation of the TSH receptor gene in both the primary tumor and the lymph node metastasis was found, due to a base substitution at codon 633 (normal guanine at position 1896 replaced by cytosine CAC for GAC causing aspartic acid substitution by histidine). Other known oncogenes (gsp, ras, PTC/ret, trk, met, and p53) were not involved. This is the first description of an activating TSH receptor mutation in a thyroid hyperfunctioning carcinoma in which an aggressive malignant phenotype coexisted with activation of the cAMP cascade and differentiated thyroid functions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9062474     DOI: 10.1210/jcem.82.3.3838

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Thyrotropin receptor mutations in thyroid diseases.

Authors:  P M Yen
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

Review 2.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

3.  Non-hyperfunctioning nodules from multinodular goiters: a minor role in pathogenesis for somatic activating mutations in the TSH-receptor and Gsalpha subunit genes.

Authors:  C Derrien; E Sonnet; I Gicquel; J Y Le Gall; J Y Poirier; V David; D Maugendre
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

4.  Genetic analysis of the TSH receptor gene in differentiated human thyroid carcinomas.

Authors:  F Cetani; M Tonacchera; A Pinchera; R Barsacchi; F Basolo; P Miccoli; F Pacini
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

Review 5.  Molecular pathobiology of thyroid neoplasms.

Authors:  Giovanni Tallini
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

6.  Similarities and differences in the phenotype of members of an Italian family with hereditary non-autoimmune hyperthyroidism associated with an activating TSH receptor germline mutation.

Authors:  F Arturi; E Chiefari; S Tumino; D Russo; S Squatrito; G Chazenbalk; L Persani; B Rapoport; S Filetti
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

7.  Congenital neonatal hyperthyroidism caused by germline mutations in the TSH receptor gene.

Authors:  Jeremy Chester; Deborah Rotenstein; Usanee Ringkananont; Guy Steuer; Beatrice Carlin; Lindsay Stewart; Helmut Grasberger; Samuel Refetoff
Journal:  J Pediatr Endocrinol Metab       Date:  2008-05       Impact factor: 1.634

8.  A somatic gain-of-function mutation in the thyrotropin receptor gene producing a toxic adenoma in an infant.

Authors:  Brenda Kohn; Helmut Grasberger; Leslie L Lam; Alfonso Massimiliano Ferrara; Samuel Refetoff
Journal:  Thyroid       Date:  2009-02       Impact factor: 6.568

9.  Early assessment of high-intensity focused ultrasound treatment of benign thyroid nodules by scintigraphic means.

Authors:  Huedayi Korkusuz; Niklas Fehre; Michael Sennert; Christian Happel; Frank Grünwald
Journal:  J Ther Ultrasound       Date:  2014-09-30

10.  A solitary hyperfunctioning thyroid nodule harboring thyroid carcinoma: review of the literature.

Authors:  Sasan Mirfakhraee; Dana Mathews; Lan Peng; Stacey Woodruff; Jeffrey M Zigman
Journal:  Thyroid Res       Date:  2013-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.